NewAmsterdam Pharma (NAMS) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free NAMS Stock Alerts $21.99 +0.55 (+2.57%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media NewAmsterdam Pharma Stock Price Performance5 Day Performance+10.34%1 Month Performance-3.21%3 Month Performance-1.39%6 Month Performance+248.49%Year-To-Date Performance+96.87%1 Year Performance+57.07% Receive NAMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. NAMS Stock Chart for Friday, April, 26, 2024 NAMS Chart by TradingView NewAmsterdam Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$21.44$21.99+2.57%$22.09$21.1362,741 shs$1.96 billion04/25/2024$21.80$21.44-1.65%$21.80$20.6587,902 shs$1.91 billion04/24/2024$21.45$21.80+1.63%$22.24$21.41118,387 shs$1.95 billion04/23/2024$20.23$21.45+6.03%$22.20$19.91170,366 shs$1.91 billion04/22/2024$19.93$20.23+1.51%$20.67$20.0185,269 shs$1.81 billion04/19/2024$19.44$19.93+2.52%$20.32$19.21140,271 shs$1.78 billion Get the Latest News and Ratings for NAMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$20.05$19.44-3.04%$21.14$19.33222,127 shs$1.74 billion04/17/2024$19.50$20.05+2.82%$20.06$19.02104,258 shs$1.79 billion04/16/2024$19.74$19.50-1.22%$20.26$18.751.23 million shs$1.74 billion04/15/2024$19.70$19.74+0.20%$20.21$19.18268,390 shs$1.76 billion04/12/2024$19.93$19.70-1.15%$20.00$19.4540,992 shs$1.76 billion04/11/2024$19.10$19.93+4.35%$19.96$19.1756,058 shs$1.78 billion04/10/2024$18.95$19.10+0.79%$19.59$18.22260,844 shs$1.71 billion04/09/2024$19.61$18.95-3.37%$20.00$18.77435,195 shs$1.69 billion04/08/2024$20.80$19.61-5.72%$20.99$19.50218,570 shs$1.75 billion04/05/2024$21.41$20.80-2.85%$22.12$20.77253,932 shs$1.86 billion04/04/2024$22.11$21.41-3.17%$22.40$21.27133,370 shs$1.91 billion04/03/2024$21.40$22.11+3.32%$22.16$21.3393,459 shs$1.97 billion04/02/2024$21.37$21.40+0.14%$22.51$20.50159,784 shs$1.91 billion04/01/2024$23.65$21.37-9.64%$24.79$21.37332,552 shs$1.91 billion03/29/2024$23.65$23.65$23.75$22.26293,183 shs$2.11 billion03/28/2024$22.70$23.65+4.19%$23.75$22.26292,386 shs$2.11 billion03/27/2024$22.72$22.70-0.09%$22.86$22.51115,147 shs$2.03 billion03/26/2024$22.46$22.72+1.16%$23.39$22.31332,630 shs$2.03 billion03/25/2024$22.27$22.46+0.85%$22.61$21.98193,004 shs$2.01 billion03/22/2024$22.45$22.27-0.80%$23.03$21.90112,055 shs$1.99 billion03/21/2024$22.14$22.45+1.40%$22.45$21.7667,786 shs$2.00 billion03/20/2024$22.05$22.14+0.41%$22.36$21.5084,413 shs$1.98 billion03/19/2024$22.04$22.05+0.05%$22.42$21.8546,056 shs$1.97 billion03/18/2024$22.03$22.04+0.05%$22.95$21.3830,045 shs$1.97 billion03/15/2024$21.93$22.03+0.46%$22.05$21.2635,824 shs$1.97 billion03/14/2024$22.30$21.93-1.66%$23.10$21.6995,164 shs$1.96 billion03/13/2024$23.43$22.30-4.82%$23.75$21.93143,292 shs$1.99 billion03/12/2024$20.94$23.43+11.89%$24.00$20.91484,223 shs$2.09 billion03/11/2024$20.97$20.94-0.14%$21.40$20.62267,680 shs$1.87 billion03/08/2024$20.92$20.97+0.24%$21.50$20.38291,903 shs$1.73 billion03/07/2024$22.04$20.92-5.08%$22.19$20.29131,275 shs$1.72 billion03/06/2024$22.27$22.04-1.03%$22.83$21.89237,849 shs$1.81 billion03/05/2024$23.05$22.27-3.38%$23.31$21.56145,316 shs$1.83 billion03/04/2024$23.54$23.05-2.08%$23.74$22.32127,689 shs$1.90 billionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$22.84$23.54+3.06%$24.56$22.97268,611 shs$1.94 billion02/29/2024$23.62$22.84-3.30%$24.99$22.59169,698 shs$1.88 billion02/28/2024$24.23$23.62-2.52%$24.91$22.83258,355 shs$1.94 billion02/27/2024$22.06$24.23+9.84%$24.74$21.96446,622 shs$1.99 billion02/26/2024$23.14$22.06-4.67%$23.69$21.51141,229 shs$1.82 billion02/23/2024$21.55$23.14+7.38%$23.74$21.27312,476 shs$1.89 billion02/22/2024$21.56$21.55-0.05%$22.40$21.07374,983 shs$1.76 billion02/21/2024$21.12$21.56+2.08%$21.73$20.05117,312 shs$1.76 billion02/20/2024$20.72$21.12+1.93%$22.58$20.51273,462 shs$1.72 billion02/19/2024$20.72$20.72$20.76$19.70169,300 shs$1.69 billion02/16/2024$19.67$20.72+5.34%$20.75$19.77169,318 shs$1.69 billion02/15/2024$20.05$19.67-1.90%$20.85$19.66692,708 shs$1.60 billion02/14/2024$20.00$20.05+0.25%$20.16$19.301.24 million shs$1.64 billion02/13/2024$20.77$20.00-3.71%$20.48$19.00151,495 shs$1.63 billion02/12/2024$20.45$20.77+1.56%$22.48$20.50161,785 shs$1.69 billion02/09/2024$19.57$20.45+4.50%$20.74$19.98123,361 shs$1.67 billion02/08/2024$20.60$19.57-5.00%$20.75$19.09183,682 shs$1.60 billion02/07/2024$20.00$20.60+3.00%$20.70$19.6391,757 shs$1.68 billion02/06/2024$19.97$20.00+0.15%$20.13$19.3798,250 shs$1.63 billion02/05/2024$19.55$19.97+2.15%$20.00$19.0395,428 shs$1.63 billion02/02/2024$20.80$19.55-6.01%$21.26$18.70152,474 shs$1.59 billion02/01/2024$20.47$20.80+1.61%$20.90$20.06145,379 shs$1.70 billion01/31/2024$19.94$20.47+2.66%$21.15$19.21303,342 shs$1.67 billion01/30/2024$20.33$19.94-1.92%$20.03$17.13371,610 shs$1.63 billion01/29/2024$22.30$20.33-8.83%$24.17$20.00442,435 shs$1.66 billion01/26/2024$24.01$22.30-7.12%$25.26$21.98340,039 shs$1.82 billion01/25/2024$23.15$24.01+3.71%$26.35$20.59316,086 shs$1.96 billion Related Companies: Geron Stock Price Chart Galapagos Stock Price Chart Maravai LifeSciences Stock Price Chart PTC Therapeutics Stock Price Chart Keros Therapeutics Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Avidity Biosciences Stock Price Chart Schrödinger Stock Price Chart Agios Pharmaceuticals Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Receive NAMS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NAMS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.